Today: 30 April 2026
Melrose Industries share price sinks 13% as 2026 outlook spooks investors
27 February 2026
1 min read

Melrose Industries share price sinks 13% as 2026 outlook spooks investors

London, February 27, 2026, 11:21 GMT — Regular session

  • Melrose shares dropped after the company signaled it expects lower revenue in 2026.
  • Despite a solid 2025 performance, supply-chain snags and doubts around tariffs took the spotlight.
  • The group has increased its dividend and rolled out a new share buyback programme.

Shares of Melrose Industries PLC slid 13.4% to 554 pence as of 11:06 GMT Friday, putting the GKN Aerospace parent at the bottom of the FTSE 100. The stock touched a session low of 536.8 pence after investors balked at the company’s guidance for 2026.

This slide is grabbing attention because aerospace suppliers are being judged on their ability to convert historic demand into actual shipments—not on last year’s recovery. Melrose cited ongoing supply-chain snags and uncertainty linked to U.S. trade policy, and put its 2026 revenue outlook at 3.75 billion to 3.95 billion pounds, trailing the 4.01 billion analysts penciled in. Chief Executive Peter Dilnot told Reuters that chokepoints at Airbus, Pratt & Whitney and GE remain the biggest headache for meeting orders.

Melrose said 2025 revenue was up 8% to 3.589 billion pounds, with adjusted operating profit jumping 23% to 647 million pounds. Free cash flow came in at 125 million pounds. The company also set out plans for a fresh 175 million pound share buyback, targeting completion by end-March 2027. The final dividend moves 20% higher to 4.8 pence per share, due May 5 for holders recorded as of March 20 close.

Melrose is positioning as a focused aerospace and defence supplier, manufacturing engine and airframe parts via GKN Aerospace. Increasingly, profits are being driven by the “aftermarket” — essentially, repairs and spare parts for planes already in service. That business is typically more stable than revenue from new aircraft production.

The action Friday underscored just how fast “guidance” can overshadow headline earnings. Hopes around smoother production ramps are still in play, but behind the scenes, the process remains tangled. Even minor hiccups at major planemakers can cascade.

This week, other UK aerospace stocks have told a different story. Rolls-Royce jumped the previous day, buoyed by a raised outlook and a new 2026–2028 buyback plan, setting the tone ahead of Melrose’s results.

Melrose put it less bluntly—demand’s not the issue, it’s whether capacity can keep up. Investors, meanwhile, are left weighing tariff risks and unpredictable trade tensions that reshuffle costs before contracts even catch up.

Risks here aren’t subtle—and they’re hardly minor. Ongoing shortages or shaky build rates at key customers could push deliveries into future quarters, squeezing margins as suppliers shell out more for labor, parts, and rush shipping.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
CRISPR Therapeutics stock whipsaws again as takeover talk resurfaces — here’s what to watch
Previous Story

CRISPR Therapeutics stock whipsaws again as takeover talk resurfaces — here’s what to watch

GRAIL stock dips in premarket after a sharp bounce as Galleri trial fallout hangs over GRAL
Next Story

GRAIL stock dips in premarket after a sharp bounce as Galleri trial fallout hangs over GRAL

Go toTop